Actas - Consejo de los ADPIC - Ver detalles de la intervención/declaración

Ambassador Alfredo Suescum (Panama)
223. The Government of Canada considers access to medicines to be a key priority in our ongoing efforts to promote global health and prosperity, and welcomes the attention that the Report of the UN Secretary General’s High-Level Panel on Access to Medicines has drawn to this important issue. 224. The Government of Canada continues to review the detailed Report of the High-Level Panel and its various recommendations. For Canada, these recommendations touch upon a variety of complex domestic policies, laws, and regulations, not only in respect of IP, but also areas such as pricing, public funding for research and development, governance, accountability, and transparency, and which fall under the responsibility of a variety of Federal Government departments and agencies. 225. While there are a number of recommendations that are not in line with our current practice, there are also other recommendations that may be consistent with the Government of Canada’s approach to the promotion of access to medicines and which we continue to reflect upon. The Government of Canada will therefore require further time to consider the Report’s recommendations in more detail. At the same time, Canada is pleased to participate in discussions on this issue today. 226. Canada recognizes that improving access to medicines needs to be achieved through the promotion of health equity, stronger health systems, and universal health coverage. Indeed, Canada’s international development priorities and significant investments in strengthening health systems and the health and rights of women and children are contributing to improved access in this regard. 227. Canada is a global leader in supporting partnerships such as the Global Fund to Fight AIDS, Tuberculosis and Malaria; the Global Drug Facility; and Gavi, The Vaccine Alliance, which strengthens health systems and provides targeted programming to increase access to medicines and vaccines. In September 2016, Canada hosted the Fifth Replenishment Conference of the Global Fund, and pledged CAD $804 million (or roughly USD $613 million) for 2017 to 2019. Canada is also the sixth largest donor to Gavi, having pledged CAD $520 million (or USD $396 million) for the 2016-2020 period. 228. Once again, Canada is pleased to be part of the discussion on this important issue, and to have the opportunity to share our own experiences on the promotion of access to medicines. Along these lines, Canada looks forward to learning more about the views of other Members as they continue to reflect on the various recommendations made in the Report of the High-Level Panel.
The Council took note of the statements made.
63. The Chairman recalled that Brazil, China, India and South Africa had requested that this item be added to the agenda of the Council's meeting in November 2016. To introduce the item, they had also submitted a communication (document IP/C/W/619).

64. In the course of that discussion, the delegation of South Africa had requested that this item be continued as an ad hoc item at the next meeting and the Council so agreed.

65. Since this was a continuation of the discussion had held at the Council's meeting in November 2016, he briefly summarized what had been said at that meeting. According to the co sponsors, the request to add this item to the Council's agenda had been intended to facilitate an exchange of views on the recommendations of the High Level Panel, as well as to share national experiences regarding the use of TRIPS flexibilities. At the meeting in November 2016, some delegations had welcomed the discussion of the report in this Council while others had said that they needed more time to consider the recommendations. Some delegations had expressed concern about the narrow scope of the report and had noted that it had neither been mandated nor endorsed by Members of the United Nations.

66. The representatives of India; Bangladesh on behalf of the LDC Group; Brazil; South Africa; China; Indonesia; Nigeria on behalf of the African Group; Egypt; the United States; Japan; Canada; the Republic of Korea; Norway; the European Union; Switzerland; Australia; Chinese Taipei; and Chile took the floor.

67. The representative of the World Health Organization took the floor.

68. The Council took note of the statements made.

IP/C/M/85, IP/C/M/85/Add.1